Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Mollie B. Smith
Observed name:
Mollie Smith
Institutions:
University of Massachusetts Chan Medical School,
University of California, San Francisco
Observed institutions:
University of Massachusetts Chan Medical School,
University of California, San Francisco,
Toronto Metropolitan University,
Mount Royal University
ORCID:
0009-0002-7240-7865
Observed ORCID:
0009-0002-7240-7865
OpenAlex ID:
A5104240279
Optimizing the patient journey: Insights from early implementation of long‐acting cabotegravir and rilpivirine in four urban Ryan White‐funded clinics in the United States
2026
·
Xavier A. Erguera
, Mollie B. Smith
, et al.
·
Journal of the International AIDS Society
·
3
PDF
P-578. Just “Short of a Cure”: Unique Considerations in Uptake and Use of Long-Acting Injectable Cabotegravir/Rilpivirine Among Long-Term Survivors with HIV
2025
·
Priyasha Pareek
, Lauren F Collins
, et al.
·
Open Forum Infectious Diseases
·
1
1585. The Annual Cost per Newly Virally-Suppressed Person with HIV in Those Starting Long-Acting Injectable Antiretroviral Therapy with Detectable Viremia in a Safety-Net Clinic in San Francisco
2023
·
Elliot Marseille
, Ryan Walker
, et al.
·
Open Forum Infectious Diseases
·
1
PDF
What Do People with HIV Want to Know About Long-Acting Injectable Cabotegravir/Rilpivirine?
2026
·
Alicia Dawdani
, Kaylin V. Dance
, et al.
·
AIDS and Behavior
PDF
Physician–Industry Payments in the Skin Substitute Market—Shedding Light From the Sunshine Act
2026
·
Mollie Smith
, Chandler Hinson
, et al.
·
Journal of Burn Care & Research
17 Physician-industry Payments in the Skin Substitute Market—Shedding Light from the Sunshine Act
2025
·
Chandler Hinson
, Mollie Smith
, et al.
·
Journal of Burn Care & Research
Online Learning During COVID-19
2024
·
Mollie Smith
PDF
Show more works
View as search
Works count:
7
Citation count:
5
H-index:
1
I10-index:
Year
Topic
Type